Literature DB >> 30374794

EUS-guided irreversible electroporation using endoscopic needle-electrode in porcine pancreas.

Jae Min Lee1, Hyuk Soon Choi1, Hoon Jai Chun2, Eun Sun Kim1, Bora Keum1, Yeon Seok Seo1, Yoon Tae Jeen1, Hong Sik Lee1, Soon Ho Um1, Chang Duck Kim1, Hong Bae Kim3.   

Abstract

BACKGROUND: Endoscopic irreversible electroporation (IRE) can be performed using a flexible, thin, needle-shaped electrode for an endoscopic ultrasound (EUS)-guided procedure. This study aimed to evaluate the feasibility and efficacy of performing EUS-guided IRE with endoscopic needle-electrode in porcine pancreas.
METHODS: Experimental endoscopic IRE on the pancreas were performed by EUS-guided approach in three pigs and compared with surgical approach in three pigs. The animals were killed after 24 h and their pancreases collected.
RESULTS: IRE ablation using endoscopic needle-electrode was successful technically in EUS-guided approaches for the pancreas. Immediately following IRE, the ablated pancreatic tissue showed no gross change except focal hemorrhage. H&E staining presented a well-demarcated ablation site measuring 1.0-1.5 cm in diameter in the pancreas. TUNEL immunohistochemistry showed diffuse cell death along the puncture site 24 h after IRE. No complication was observed in pigs after endoscopic IRE ablation.
CONCLUSION: EUS-guided IRE ablation was feasible and effective for pancreas using the newly developed device.

Entities:  

Keywords:  Animal; EUS; Endoscopy; Irreversible electroporation; Pancreas

Mesh:

Year:  2018        PMID: 30374794     DOI: 10.1007/s00464-018-6425-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  11 in total

1.  Use of irreversible electroporation in unresectable pancreatic cancer.

Authors:  Robert C G Martin
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

2.  Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.

Authors:  Edward W Lee; Christopher T Loh; Stephen T Kee
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 3.  Nonthermal irreversible electroporation: fundamentals, applications, and challenges.

Authors:  Alexander Golberg; Martin L Yarmush
Journal:  IEEE Trans Biomed Eng       Date:  2013-01-09       Impact factor: 4.538

Review 4.  Pancreatic adenocarcinoma.

Authors:  David P Ryan; Theodore S Hong; Nabeel Bardeesy
Journal:  N Engl J Med       Date:  2014-09-11       Impact factor: 91.245

5.  EUS-guided radiofrequency ablation in the pancreas: results in a porcine model.

Authors:  S N Goldberg; S Mallery; G S Gazelle; W R Brugge
Journal:  Gastrointest Endosc       Date:  1999-09       Impact factor: 9.427

6.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.

Authors:  Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

Review 7.  Progress in the treatment of metastatic pancreatic cancer and the search for next opportunities.

Authors:  Andrew H Ko
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 8.  Endoscopic Ultrasound-Guided Direct Intervention for Solid Pancreatic Tumors.

Authors:  Jimin Han; Kenneth J Chang
Journal:  Clin Endosc       Date:  2017-03-30

Review 9.  Systemic Chemotherapy in Advanced Pancreatic Cancer.

Authors:  Hee Seung Lee; Seung Woo Park
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

10.  A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas.

Authors:  David Stillström; Henrik Nilsson; Michaela Jesse; Matthias Peterhans; Eduard Jonas; Jacob Freedman
Journal:  Surg Endosc       Date:  2016-08-29       Impact factor: 4.584

View more
  8 in total

Review 1.  Irreversible Electroporation of the Pancreas.

Authors:  Gabriel Chan; Uei Pua
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

2.  Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation.

Authors:  Fenggang Ren; Qingshan Li; Liangshuo Hu; Xiaopeng Yan; Zhongyang Gao; Jing Zhang; Weiman Gao; Zhe Zhang; Pengkang Chang; Xue Chen; Dake Chu; Rongqian Wu; Yi Lv
Journal:  Surg Endosc       Date:  2019-04-22       Impact factor: 4.584

3.  Endoscopic Ultrasound-Guided Laser Ablation Using a Diffusing Applicator for Locally Advanced Pancreatic Cancer Treatment.

Authors:  Seonghee Lim; Van Gia Truong; Jongman Choi; Hye Jung Jeong; Sun-Ju Oh; Jin-Seok Park; Hyun Wook Kang
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

Review 4.  An Overview of Cell Membrane Perforation and Resealing Mechanisms for Localized Drug Delivery.

Authors:  Stephanie He; Davindra Singh; Brandon Helfield
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

5.  Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Yu-Ze Jia; Xiang-Long Tan; Yu-Yao Song
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

6.  Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal Study.

Authors:  Kang Won Lee; Jae Min Lee; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yeon Seok Seo; Yoon Tae Jeen; Soon Ho Um; Hong Sik Lee; Hoon Jai Chun; Chang Duck Kim; Chi Hyuk Oh; Hong Bae Kim
Journal:  Clin Endosc       Date:  2020-10-20

7.  Evaluation of electroporated area using 2,3,5-triphenyltetrazolium chloride in a potato model.

Authors:  Seung Jeong; Hongbae Kim; Junhyung Park; Ki Woo Kim; Sung Bo Sim; Jong Hoon Chung
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

8.  Radioactive 125I seed implantation for locally advanced pancreatic cancer: A retrospective analysis of 50 cases.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Yu-Ze Jia; Xiang-Long Tan; Yu-Yao Song
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.